Bausch + Lomb Corporation (BLCO) vs Repligen Corporation (RGEN)
- Bausch + Lomb Corporation BLCO 16.40 −1.56%
- Repligen Corporation RGEN 175.20 −4.87%
Bausch + Lomb Corporation and Repligen Corporation are both Medical Instruments & Supplies companies. Repligen Corporation is the larger, with a market value of $11.7B against $6.0B — 2.0× the size. Bausch + Lomb Corporation has negative trailing earnings, so its P/E is not meaningful; Repligen Corporation trades at 234×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 8.85%. Repligen Corporation has the higher net margin (5.29% vs −3.21%) and the higher return on invested capital (2.18% vs 1.81%). Across the 21 metrics below, Repligen Corporation leads on 13 and Bausch + Lomb Corporation on 8.
Valuation
Profitability
| Metric | BLCO | RGEN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 61.44% | 53.52% | 54.29% |
| Operating margin | 6.07% | 8.23% | 1.07% |
| Net margin | (3.21%) | 5.29% | (1.61%) |
| Free cash flow margin | 2.57% | 14.06% | 1.08% |
| Return on equity | (2.64%) | 1.99% | (1.32%) |
| Return on assets | (1.24%) | 1.42% | 0.00% |
| Return on invested capital | 1.81% | 2.18% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack